Catalyst Pharmaceuticals, Inc.
NASDAQCatalyst Pharmaceuticals reports Q1 2026 results today, May 12, having just posted its sharpest rally in months — with two sell-side downgrades arriving at the door. The stock gained 25% over the past month and 7.6% in the past week alone, closing at $31.15. That rally has effectively priced in a lot of good news. It has also prompted two immediate pushbacks from the Street…
Snapshot as of 12 May 2026
Catalyst Pharmaceuticals reports Q1 2026 results today, May 12, having just posted its sharpest rally in months — with two sell-side downgrades arriving at the door. The stock gained 25% over the past month and 7.6% in…
Catalyst Pharmaceuticals goes into its May 11 Q1 results with the Street cooling on a name that has surged 25% in a month. Two downgrades landed in the two days before the print. Citigroup moved the stock to Neutral…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CPRX — free to start on ORTEX.
Sign up for free →Open CPRX on ORTEX